Basis of Presentation - Schedule of Impacts of Correcting the Consolidated Statement of Cash Flow (Details) - USD ($) $ in Thousands	5 Months Ended	7 Months Ended	12 Months Ended
	Dec. 31, 2022	Jul. 24, 2022	Dec. 31, 2023	Dec. 31, 2021	Dec. 31, 2020
Condensed Cash Flow Statements, Captions [Line Items]
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures — Accounts payable	$ (40,102)	$ 44,446	$ (40,489)	$ 72,260
Net cash provided by operating activities	179,047	331,067	400,184	(211,875)
Net increase in cash, cash equivalents and restricted cash	(534,228)	693,332	(84,674)	(279,808)
Cash and cash equivalents at end of period	$ 553,551	1,087,779	$ 468,877	$ 394,447	$ 674,255
As Reported
Condensed Cash Flow Statements, Captions [Line Items]
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures — Accounts payable		64,044
Net cash provided by operating activities		350,665
Net increase in cash, cash equivalents and restricted cash		712,930
Cash and cash equivalents at end of period		1,109,588
Adjustment
Condensed Cash Flow Statements, Captions [Line Items]
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures — Accounts payable		(19,598)
Net cash provided by operating activities		(19,598)
Net increase in cash, cash equivalents and restricted cash		(19,598)
Cash and cash equivalents at end of period		$ (21,809)